Medicare Payment Advisory Commission’s (MedPAC) Comments on High-Risk Medical Devices

A Medicare Payment Advisory Commission’s (MedPAC) session examination of the process for approving high-risk medical devices produced discussion on the potential for long-term patient care quality problems. As a result, it is anticipated that changes in approval regulations may be forthcoming. Read an analysis of the issue by Bloomberg BNA reporter Michael Williamson here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s 
 validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.